GO:0141163 positive regulation of cAMP/PKA signal transduction: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0141163 describes any process that activates or increases the frequency, rate or extent of cAMP/PKA signal transduction, a central intracellular signaling cascade.
• The pathway is initiated by G-protein-coupled receptors that activate Gαs, leading to adenylyl cyclase stimulation and cAMP production, which in turn activates protein kinase A (PKA).
• Positive regulation of cAMP/PKA signaling is critical for diverse physiological processes including immune regulation, metabolism, and cell proliferation.
• Dysregulation of this pathway is implicated in cancers, chronic viral infections, and metabolic disorders, making it a target for therapeutic intervention.
• Key genes involved include GNAS, GPR176, MEDAG, and CTLA-4, which modulate cAMP levels or PKA anchoring.
• CRISPR-based knockout, knock-in, and overexpression models are essential tools for dissecting the causal roles of genes in this pathway.
Description
The Gene Ontology term GO:0141163, positive regulation of cAMP/PKA signal transduction, refers to any process that activates or increases the frequency, rate or extent of the cAMP-dependent protein kinase A signaling cascade. This pathway is one of the most ubiquitous intracellular signaling mechanisms, converting extracellular signals into cellular responses such as gene expression, metabolism, and cell survival. Understanding its positive regulation is fundamental because it governs key physiological outputs, from immune cell activation to metabolic homeostasis. In recent years, research has uncovered diverse molecular players that enhance cAMP/PKA signaling, including G-protein-coupled receptors, A-kinase anchoring proteins, and viral or oncogenic factors. These findings have broad implications for cancer, infectious diseases, and metabolic disorders, driving interest in precise genetic models to study this process. This article synthesizes current knowledge based on QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0141163.
positive regulation of cAMP/PKA signal transduction At A Glance
| GO ID | GO:0141163 |
|---|---|
| GO term | positive regulation of cAMP/PKA signal transduction |
| Ontology | biological_process |
| Synonym | positive regulation of cAMP/PKA signaling |
| Definition | Any process that activates or increases the frequency, rate or extent of cAMP/PKA signal transduction. |
| Major function | Enhances cAMP production and PKA activation, leading to phosphorylation of downstream targets. |
| Related pathways | GPCR signaling, Gαs-mediated adenylyl cyclase activation, PKA anchoring and substrate phosphorylation. |
| Key regulators | GNAS, GPR176, MEDAG, CTLA-4, and viral factors such as HBV proteins. |
What Is GO:0141163?
According to the Gene Ontology, GO:0141163 is defined as any process that activates or increases the frequency, rate or extent of cAMP/PKA signal transduction. In other words, it encompasses all molecular events that positively regulate the signaling cascade initiated by cyclic AMP (cAMP) and executed by protein kinase A (PKA). This includes mechanisms that elevate cAMP levels, enhance PKA activity, or promote downstream phosphorylation events.
Why Is positive regulation of cAMP/PKA signal transduction Important in Cell Biology?
Positive regulation of cAMP/PKA signal transduction is essential for a wide array of physiological and pathological processes. It controls immune cell function, as shown by increased cAMP-PKA activation driving CTLA-4 upregulation in CD4+ T cells during acute SIV infection. In chronic HBV infection, a liver immune rheostat involving cAMP/PKA signaling regulates CD8 T cell immunity. The pathway also influences cancer progression; for example, GPR176 promotes colorectal cancer by interacting with GNAS to restrain mitophagy. Additionally, MEDAG functions as an A-kinase-anchoring protein in adipocytes, linking cAMP/PKA signaling to metabolic regulation. These examples underscore the importance of understanding how this pathway is positively regulated in health and disease.
• Regulates immune responses, including T cell activation and exhaustion in chronic viral infections.
• Modulates cancer cell proliferation, survival, and mitophagy, with implications for colorectal cancer and pituitary tumors.
• Controls metabolic processes such as adipocyte function and glucose homeostasis through A-kinase anchoring proteins.
• Plays a role in β-cell mitochondrial remodeling and insulin secretion via GLP-1R-associated complexes.
• Influences fungal cellulose utilization and sporulation, highlighting evolutionary conservation.
• Serves as a target for therapeutic intervention in diseases like cancer, HBV, and SIV/HIV.
• Provides a paradigm for GPCR-mediated signal transduction, a major drug target class.
• Its dysregulation can lead to endocrine disorders, as seen in pituitary tumors with oncogene activation.
What Happens During positive regulation of cAMP/PKA signal transduction?
Receptor Activation and G-protein Coupling
In simple terms: A signal molecule binds to a receptor on the cell surface, which then activates a G-protein inside the cell.
Positive regulation often begins with the binding of an agonist to a G-protein-coupled receptor (GPCR) that couples to Gαs. This interaction promotes the exchange of GDP for GTP on Gαs, leading to its activation. For instance, GPR176 interacts with GNAS to modulate cAMP signaling in colorectal cancer. Similarly, GLP-1R associates with VAPB and SPHKAP at ER-mitochondria contact sites to regulate β-cell function. These receptor-proximal events are critical for initiating the cascade.
Adenylyl Cyclase Activation and cAMP Production
In simple terms: The activated G-protein turns on an enzyme that produces cAMP, a small molecule that acts as a second messenger.
Activated Gαs stimulates adenylyl cyclase (AC), which catalyzes the conversion of ATP to cyclic AMP (cAMP). This step is a key point of positive regulation. In Chaetomium globosum, the Gα-cAMP/PKA pathway is regulated during cellulose utilization, indicating that AC activity is modulated by environmental cues. Increased cAMP levels then serve as a signal to activate downstream effectors.
PKA Activation and Substrate Phosphorylation
In simple terms: cAMP binds to PKA, causing it to release its catalytic subunits that then add phosphate groups to target proteins.
The binding of cAMP to the regulatory subunits of protein kinase A (PKA) releases the catalytic subunits, which phosphorylate serine/threonine residues on substrate proteins. This phosphorylation alters their activity, localization, or stability. In CD4+ T cells from SIV-infected macaques, increased cAMP-PKA signaling leads to upregulation of CTLA-4, a key immune checkpoint. MEDAG acts as an A-kinase-anchoring protein (AKAP) in adipocytes, spatially organizing PKA to specific substrates.
Anchoring and Compartmentalization
In simple terms: Scaffold proteins hold PKA in specific locations to ensure it acts on the right targets.
A-kinase-anchoring proteins (AKAPs) bind PKA and target it to distinct subcellular compartments, enhancing specificity and efficiency of signal transduction. MEDAG was recently identified as an AKAP in adipocytes, where it regulates lipid metabolism. This compartmentalization is a form of positive regulation because it concentrates PKA near its substrates, increasing the rate and extent of phosphorylation.
Cross-talk with Other Signaling Pathways
In simple terms: The cAMP/PKA pathway communicates with other signaling systems to fine-tune cellular responses.
Positive regulation of cAMP/PKA signaling often involves integration with other pathways. For example, in chronic HBV infection, a liver immune rheostat involving cAMP/PKA modulates CD8 T cell immunity, likely through cross-talk with inflammatory signals. In pituitary tumors, oncogene activation can enhance cAMP/PKA signaling, contributing to tumorigenesis. Such cross-talk amplifies or sustains the signal, representing another layer of positive regulation.
Key Genes Involved in GO:0141163 positive regulation of cAMP/PKA signal transduction
The following genes and proteins are key players in the positive regulation of cAMP/PKA signal transduction, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GNAS | Encodes Gαs subunit that activates adenylyl cyclase | Mutations in GNAS are found in pituitary tumors and other endocrine neoplasms. |
| GPR176 | Orphan GPCR that interacts with GNAS to modulate cAMP | Promotes colorectal cancer progression by restraining mitophagy. |
| MEDAG | A-kinase-anchoring protein in adipocytes | Regulates lipid metabolism and PKA substrate specificity. |
| CTLA-4 | Immune checkpoint upregulated by cAMP/PKA | Increased expression in CD4+ T cells during acute SIV infection. |
| GLP-1R | GPCR that activates cAMP/PKA in β-cells | Associates with VAPB and SPHKAP at ERMCSs to regulate mitochondrial remodeling. |
| VAPB | ER-mitochondria tethering protein | Part of GLP-1R complex affecting β-cell function. |
| SPHKAP | A-kinase anchoring protein | Interacts with GLP-1R at ERMCSs. |
| PKA (PRKACA, PRKAR1A) | cAMP-dependent protein kinase | Central effector of cAMP signaling; mutations in PRKAR1A cause Carney complex. |
| Adenylyl cyclase (ADCY) | Synthesizes cAMP from ATP | Target of Gαs; multiple isoforms regulate distinct cellular responses. |
| HBV proteins | Modulate liver immune rheostat | Regulate CD8 T cell immunity via cAMP/PKA in chronic HBV. |
| SIV/HIV factors | Enhance cAMP-PKA activation | Upregulate CTLA-4 in CD4+ T cells. |
| Oncogenes (e.g., GNAS, PRKACA) | Activate cAMP/PKA signaling | Drive pituitary tumorigenesis. |
| Fungal Gα proteins | Regulate cAMP/PKA in cellulose utilization | Model for conserved pathway in Chaetomium globosum. |
| Ashbya gossypii sporulation genes | Regulate cAMP/PKA during sporulation | Fungal developmental model. |
How Is positive regulation of cAMP/PKA signal transduction Regulated?
The positive regulation of cAMP/PKA signal transduction is itself tightly regulated at multiple levels. Receptor desensitization, phosphodiesterase-mediated cAMP degradation, and protein phosphatase activity provide negative feedback. Conversely, positive regulation can be achieved by increased expression or activity of Gαs, adenylyl cyclase, or PKA subunits, as well as by AKAPs that enhance coupling efficiency. In chronic HBV infection, a liver immune rheostat involving cAMP/PKA modulates CD8 T cell immunity, suggesting that viral factors can tip the balance toward positive regulation. In cancer, oncogenic mutations in GNAS or PRKACA lead to constitutive activation. Thus, the pathway is controlled by a complex interplay of stimulatory and inhibitory inputs.
positive regulation of cAMP/PKA signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR176 | Colorectal cancer | Knockout of GPR176 in HCT116 cells to assess mitophagy and proliferation. |
| GNAS | Pituitary tumors, McCune-Albright syndrome | Point mutation (R201C) knock-in in pituitary cell lines. |
| CTLA-4 | SIV/HIV immune exhaustion | Overexpression of CTLA-4 in CD4+ T cells from macaques. |
| MEDAG | Metabolic disorders, obesity | Adipocyte-specific knockout in mice. |
| GLP-1R | Type 2 diabetes | Knock-in of tagged GLP-1R in β-cell lines. |
Cancer
Dysregulated positive regulation of cAMP/PKA signaling contributes to cancer. GPR176 promotes colorectal cancer progression by interacting with GNAS to restrain mitophagy, thereby enhancing tumor cell survival. In pituitary tumors, oncogene activation often involves mutations in GNAS or other components of the cAMP/PKA pathway, leading to excessive signaling. These findings highlight the pathway as a potential therapeutic target.
Chronic Viral Infections
In chronic HBV infection, a liver immune rheostat involving cAMP/PKA signaling regulates CD8 T cell immunity, contributing to immune exhaustion. Similarly, in acute SIVmac239 infection, increased cAMP-PKA activation upregulates CTLA-4 in CD4+ T cells, which may impair antiviral responses. These studies suggest that positive regulation of cAMP/PKA is a mechanism of immune evasion by viruses.
Metabolic Disorders
MEDAG functions as an A-kinase-anchoring protein in adipocytes, linking cAMP/PKA signaling to lipid metabolism. GLP-1R, which activates cAMP/PKA, associates with VAPB and SPHKAP at ER-mitochondria contact sites to regulate β-cell mitochondrial remodeling and function. Dysregulation of these processes may contribute to obesity and diabetes.
From positive regulation of cAMP/PKA signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GPR176 promote cancer via cAMP/PKA? | GPR176 knockout in colorectal cancer cell lines. |
| How does GNAS mutation affect pituitary tumorigenesis? | GNAS R201C point mutation knock-in in pituitary cells. |
| What is the role of MEDAG in adipocyte metabolism? | MEDAG knockout or overexpression in 3T3-L1 adipocytes. |
| How does CTLA-4 upregulation affect T cell function? | CTLA-4 overexpression in primary CD4+ T cells. |
| Does GLP-1R complex regulate β-cell mitochondria? | Tagged knock-in of GLP-1R in INS-1 cells. |
| Is the cAMP/PKA pathway conserved in fungi? | Knockout of Gα gene in Chaetomium globosum. |
How to Study the positive regulation of cAMP/PKA signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for pathway activity | Identify novel regulators of cAMP/PKA. |
| Phosphoproteomics | PKA substrate phosphorylation | Map signaling downstream of GPCRs. |
| FRET cAMP sensor imaging | Real-time cAMP levels | Validate positive regulators in live cells. |
| RNA-seq | Transcriptional changes | Assess downstream effects of pathway activation. |
| Western blot | Protein expression and phosphorylation | Confirm PKA activation and substrate phosphorylation. |
| Co-immunoprecipitation | Protein-protein interactions | Study AKAP-PKA complexes. |
| Luciferase reporter assay | cAMP response element (CRE) activity | Measure PKA-dependent transcription. |
| ELISA | cAMP concentration | Quantify cAMP production in cell lysates. |
CRISPR-Cas9 Knockout Screens
Genome-wide CRISPR knockout screens can identify genes whose loss alters cAMP/PKA signaling. For example, knocking out GPR176 in colorectal cancer cells revealed its role in mitophagy and tumor growth. Such screens are powerful for discovering novel regulators of the pathway.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can quantify PKA substrate phosphorylation changes upon genetic manipulation. This approach has been used to map signaling downstream of GLP-1R in β-cells and could be applied to any gene of interest.
Live-cell Imaging of cAMP Dynamics
Genetically encoded FRET-based cAMP sensors (e.g., Epac) allow real-time monitoring of cAMP levels in living cells. This method can validate positive regulators identified through screens and has been used in studies of GPCR signaling.
RNA-seq and Transcriptomics
RNA sequencing can reveal transcriptional changes downstream of cAMP/PKA activation. For instance, CTLA-4 upregulation in SIV-infected CD4+ T cells was linked to increased cAMP-PKA signaling. Transcriptomics helps place the pathway in a broader cellular context.
How CRISPR Can Be Used to Study GO:0141163 positive regulation of cAMP/PKA signal transduction
Knockout
CRISPR knockout of candidate genes is used to determine loss-of-function effects on cAMP/PKA signaling. For example, knocking out GPR176 in colorectal cancer cells reduced tumor growth and altered mitophagy, demonstrating its positive regulatory role. Similarly, knocking out MEDAG in adipocytes would test its function as an AKAP.
Point Mutation
Point mutations can mimic oncogenic activation or inactivate key residues. The GNAS R201C mutation, found in pituitary tumors, can be introduced via CRISPR to study constitutive cAMP/PKA activation. Such models are valuable for understanding disease mechanisms.
Knock-in
Knock-in of tagged proteins (e.g., GFP or HA) allows visualization and purification of pathway components. Tagged GLP-1R knock-in in β-cells enabled the study of its interactions with VAPB and SPHKAP at ER-mitochondria contact sites. This approach preserves endogenous regulation.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate gene expression to study gain-of-function. Overexpressing CTLA-4 in CD4+ T cells confirmed its upregulation by cAMP/PKA and its impact on immune function. Overexpression models are useful for testing sufficiency.
How EDITGENE Supports positive regulation of cAMP/PKA signal transduction Research
Researchers studying positive regulation of cAMP/PKA signal transduction-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation, from knockout to knock-in, accelerating discovery in this critical signaling field.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cAMP/PKA signal transduction research.
Frequently Asked Questions About positive regulation of cAMP/PKA signal transduction
What is GO:0141163?
GO:0141163 is the Gene Ontology term for positive regulation of cAMP/PKA signal transduction, describing any process that activates or increases this signaling pathway.
What genes are involved in positive regulation of cAMP/PKA signaling?
Key genes include GNAS, GPR176, MEDAG, CTLA-4, GLP-1R, and PKA subunits, among others.
How is cAMP/PKA signaling activated?
It is activated when a GPCR stimulates Gαs, which activates adenylyl cyclase to produce cAMP, leading to PKA activation.
What diseases are associated with dysregulated cAMP/PKA signaling?
Cancers such as colorectal cancer and pituitary tumors, chronic viral infections like HBV and SIV, and metabolic disorders.
What is the role of GPR176 in cAMP/PKA signaling?
GPR176 interacts with GNAS to modulate cAMP levels and promotes colorectal cancer progression by restraining mitophagy.
How does MEDAG regulate cAMP/PKA signaling?
MEDAG functions as an A-kinase-anchoring protein in adipocytes, localizing PKA to specific substrates.
Can CRISPR be used to study cAMP/PKA signaling?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in this pathway.
What is the connection between cAMP/PKA and CTLA-4?
Increased cAMP-PKA signaling upregulates CTLA-4 expression in CD4+ T cells during acute SIV infection.
How does GLP-1R activate cAMP/PKA in β-cells?
GLP-1R associates with VAPB and SPHKAP at ER-mitochondria contact sites to regulate mitochondrial remodeling and function.
What methods are used to measure cAMP/PKA activity?
FRET sensors, phosphoproteomics, Western blot, ELISA, and luciferase reporter assays are commonly used.
Conclusion
Positive regulation of cAMP/PKA signal transduction (GO:0141163) is a fundamental biological process that amplifies a ubiquitous signaling cascade. Its dysregulation contributes to cancer, chronic infections, and metabolic diseases, making it a focal point for therapeutic development. Advances in CRISPR-based genetic models and high-throughput screening continue to uncover new regulators and effectors, offering opportunities for targeted intervention. EDITGENE's comprehensive services empower researchers to dissect this pathway with precision and speed.
References
- 1. Bosch M et al.. 2024. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection.. Nature 631(8022):867-875 PMID: 38987588
- 2. Wendland J. 2020. Sporulation in Ashbya gossypii.. J Fungi (Basel) 6(3) PMID: 32872517
- 3. Hu Y et al.. 2018. Regulation of the Gα-cAMP/PKA signaling pathway in cellulose utilization of Chaetomium globosum.. Microb Cell Fact 17(1):160 PMID: 30309363
- 4. Tian RR et al.. 2024. Increased cAMP-PKA signaling pathway activation is involved in up-regulation of CTLA-4 expression in CD4+ T cells in acute SIVmac239-infected Chinese rhesus macaques.. Virus Res 341:199313 PMID: 38244614
- 5. Tang J et al.. 2023. GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer.. Adv Sci (Weinh) 10(12):e2205627 PMID: 36905238
- 6. Long F et al.. 2026. MEDAG functions as an A-kinase-anchoring protein in adipocytes.. Mol Cell 86(5):937-953.e9 PMID: 41747731
- 7. Austin G et al.. 2025. GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function.. Nat Commun 16(1):11010 PMID: 41372122
- 8. Yu R et al.. 2001. Oncogene activation in pituitary tumors.. Brain Pathol 11(3):328-41 PMID: 11414475
